Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Thrombocythemia, Essential × apixaban × Clear all

Sponsor

Conditions

Venous Thromboembolism 5 Venous Thrombosis 4 Pulmonary Embolism 4 Neoplasms 4 Thrombosis 2 Neoplasm Metastasis 2 Intracranial Thrombosis 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Multiple Myeloma 1 Mesenteric Ischemia 1 Lymphoma 1 Hematologic Neoplasms 1

Interventions

fludarabine phosphate 13 Whole-Body Irradiation 7 Mycophenolic Acid 7 Peripheral Blood Stem Cell Transplantation 6 Cyclophosphamide 6 Busulfan 6 Cyclosporine 5 Tacrolimus 4 Antilymphocyte Serum 4 fludarabine 3 Methotrexate 3 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3 ruxolitinib 2 givinostat hydrochloride 2 givinostat 2 Melphalan 2 Etoposide 2 Carboplatin 2 veliparib 1 thymoglobulin 1 sonidegib 1 pomalidomide 1 peginterferon alfa-2a 1 bomedemstat 1 anagrelide 1 Topotecan 1 Thiotepa 1 Surveys and Questionnaires 1 Stem Cell Transplantation 1 Sirolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡